You are now leaving the Evive Biotech website. Evive offers links to other third party websites that may be of interest to our website visitors. When you click on these links you will leave the Evive’s website and will be redirected to another site. These sites are not under the control of Evive Biotech. Click Continue to proceed or Cancel to go back.
FORWARD-LOOKING STATEMENT
The information provided on this website includes forward-looking statement (collectively, the “forward-looking statements”) related to Evive Biotech Ltd. (“Evive Biotech” or “Company”). You are strongly cautioned that reliance on any forward-looking statements involves known and unknown uncertainties and risks. The forward-looking statements include, among others, those containing “plan,” “forecast,” “estimate,” “may,” “will,” “potential,” “aim,” “anticipate,” “believe,” “could,” and variations of these words or similar expressions are intended to identify forward-looking statements. These statements relate to, among other things, Evive Biotech management’s expectations regarding plans, objectives, strategies, future operating or financial performance, business plans and prospects, and expectations regarding clinical trials, development timelines, discussions with regulatory authorities, development programs, development candidates and investigational medicines under development by Evive Biotech and by Evive Biotech’s partners.
The information provided on this Website is for general information and educational purposes only. Some content is designed for specific groups of users, including employees, customers, investors and the public. The Website information you visit is subject to the Terms of Use. By accessing this Website, you agree to accept the Terms of Use unconditionality or without restriction.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the Company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the Company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
These risks and uncertainties could cause future results, performance or achievements to differ materially from the results, performance or achievements expressed or implied by such forward-looking statements. Such results, performance or achievements include, but are not limited to, the timing of enrollment or completion of clinical trials, the results of clinical trials, the timing and effects of regulatory action, the relative success or the lack of success in developing and gaining regulatory approval of Company’s product, the success, efficacy or safety of any of Company’s product, the ability to scale up, formulate and manufacture sufficient good manufacturing practices, clinical or commercialization quantities of Company’s product, and the relative success or the lack of success in the market acceptance of any of Company’s product. Drug development and commercialization involve a high degree of risk, and only a small number of research and development programs result in commercialization of a product. Results in early stage clinical trials may not be indicative of full results or results from later stage or larger scale clinical trials and do not ensure regulatory approval.
Evive Biotech undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.
No Duty to Update
The information contained in this website was current as of the date presented. Evive Biotech assumes no duty to update the information to reflect subsequent developments. Consequently, Evive Biotech will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.
You are now leaving the Evive Biotech website. Evive offers links to other third party websites that may be of interest to our website visitors. When you click on these links you will leave the Evive’s website and will be redirected to another site. These sites are not under the control of Evive Biotech. Click Continue to proceed or Cancel to go back.